Background: Lipocalin-2 is involved in various pathological conditions, such as inflammation, acute organdamage, glucose tolerance abnormalities and cancer. Lipocalin-2 is also related to reactive astrocytes in animalmodels of cerebral ischemia and traumatic brain injury (TBI). This study used a rat model of cortical contusioninjury (CCI) to observe serial changes in lipocalin-2 in brain tissue and blood over time and investigated its usefulness as a biomarker after TBI.Materials and Methods: The CCI model used in this study was male Crl:CD (Sprague–Dawley) rats. The experimental groups were divided into mild and severe groups on the basis of compression. This study examined whether the expression of lipocalin-2 significantly increased in brain tissue and blood after cortical contusion in a ratTBI model. Polymerase chain reaction (PCR) was used to quantify the expression of lipocalin-2 in brain tissue,and Western blotting and enzyme-linked immunosorbent assay (ELISA) were used to assess lipocalin-2 expression in brain tissue and blood after injury in rats.Results: PCR revealed lipocalin-2 expression in all the groups. The expression of lipidalin-2 on the side ipsilateral to the TBI site was significantly elevated at 1, 3 and 24 hours after trauma in both the mild and severe groups.Lipocalin-2 in the blood increased significantly at 3, 6 and 24 hours after trauma in the mild group and immediately after and at 1, 3, 6 and 24 hours after trauma in the severe group.Conclusion: These findings suggest that lipocalin-2 may be closely involved in the physiological condition aftersecondary damage due to TBI and may be useful as a biomarker to predict clinical outcomes after injury.
View full abstract